InvestorsHub Logo
Replies to #75560 on Biotech Values
icon url

mcbio

04/06/09 8:12 PM

#75563 RE: wallstarb #75560

O/T: Suits & Marriage

While I may be new here that doesn't mean I am NOT an empty suit.


So you're allowing for the possibility that you could be an empty suit?

My fiance has called me much worse.


Perhaps this person should remain just a fiance? lol
icon url

rkrw

04/06/09 10:05 PM

#75567 RE: wallstarb #75560

I don't think dndn needs cash and I don't think it makes sense to raise cash but they do have this which coincidentally expires this week. I have no idea how much if any they've tapped and there's limitations on how much they can take at any one time.

Dendreon Secures $130 Million Committed Equity Financing Facility

SEATTLE, WASHINGTON, October 12, 2007 – Dendreon Corporation (Nasdaq: DNDN) today announced that it has obtained a committed equity financing facility under which it may sell up to $130 million of its registered common stock to Azimuth Opportunity, Ltd. over an 18-month period. Dendreon is not obligated to utilize any of the $130 million facility and remains free to enter into and consummate other equity and debt financing transactions.

Dendreon will determine, at its sole discretion, the timing, dollar amount and floor price per share of each draw under this facility, subject to certain conditions. The number and price of shares sold in each draw are determined by a contractual formula, whereby Dendreon will issue shares to Azimuth when and if Dendreon elects to use the facility at a small discount to the volume weighted average price of Dendreon's common stock over a preceding period of trading days. Reedland Capital Partners will act as placement agent and receive a fee for its services at the time of any draw under the facility. Any shares sold under this facility will be sold pursuant to a shelf registration statement declared effective by the Securities and Exchange Commission on May 25, 2007.